{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:13:39Z","timestamp":1790730819284,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81273282"],"award-info":[{"award-number":["81273282"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81302541"],"award-info":[{"award-number":["81302541"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.cca.2014.06.015","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T11:31:33Z","timestamp":1403609493000},"page":"14-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Autoantibodies in pre-clinical autoimmune disease"],"prefix":"10.1016","volume":"437","author":[{"given":"Zhi-De","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.06.015_bb0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11926-014-0419-6","article-title":"Preclinical rheumatoid arthritis (autoantibodies): an updated review","volume":"16","author":"Deane","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cca.2014.06.015_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2007.01.006","article-title":"Autoantibodies as predictors of disease: the clinical and experimental evidence","volume":"6","author":"Bizzaro","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.06.015_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12016-007-8059-5","article-title":"The predictive significance of autoantibodies in organ-specific autoimmune diseases","volume":"34","author":"Bizzaro","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.cca.2014.06.015_bb0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.cca.2014.06.015_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.18.1.49","article-title":"Diagnostic criteria for rheumatoid arthritis: 1958 revision by a Committee of the American Rheumatism Association","volume":"18","year":"1959","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0035","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.59.2.149","article-title":"A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor","volume":"59","author":"Halldorsdottir","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0050","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2014.06.015_bb0055","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0060","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/ard.2007.085456","article-title":"Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion","volume":"67","author":"Bos","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0070","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.27570","article-title":"Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis","volume":"62","author":"Kolfenbach","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0075","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/ard.2010.131896","article-title":"Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis","volume":"70","author":"Turesson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0080","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2005.040659","article-title":"Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis","volume":"65","author":"Nielen","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/030097400750002094","article-title":"Elevation of only one rheumatoid factor isotype is not associated with increased prevalence of rheumatoid arthritis\u2014a population based study","volume":"29","author":"Jonsson","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cca.2014.06.015_bb0090","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3899\/jrheum.080895","article-title":"Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis","volume":"36","author":"Chibnik","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2014.06.015_bb0095","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2014.06.015_bb0100","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.30537","article-title":"Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis","volume":"63","author":"van de Stadt","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0105","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.06.015_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0115","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"van der Linden","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0120","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-007-0558-5","article-title":"Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis","volume":"26","author":"Kudo-Tanaka","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2014.06.015_bb0125","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0130","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2012-203165","article-title":"Drug therapy in undifferentiated arthritis: a systematic literature review","volume":"72","author":"Wevers-de Boer","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0140","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ard.2007.073825","article-title":"Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case\u2013control study nested in a cohort of Norwegian blood donors","volume":"67","author":"Jorgensen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0145","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/art.1780311004","article-title":"The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study","volume":"31","author":"del Puente","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0150","doi-asserted-by":"crossref","first-page":"e5244","DOI":"10.1136\/bmj.e5244","article-title":"Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study","volume":"345","author":"Nielsen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2014.06.015_bb0155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-120-7-199404010-00003","article-title":"Autoantibody-associated congenital heart block: outcome in mothers and children","volume":"120","author":"Waltuck","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0160","first-page":"1377","article-title":"Antinuclear antibodies heralding the onset of systemic lupus erythematosus","volume":"19","author":"Aho","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2014.06.015_bb0165","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-3083.2001.00959.x","article-title":"Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus","volume":"54","author":"Arbuckle","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cca.2014.06.015_bb0175","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/art.22665","article-title":"Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms","volume":"56","author":"Heinlen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0180","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/art.20120","article-title":"The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus","volume":"50","author":"McClain","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0185","doi-asserted-by":"crossref","first-page":"e9599","DOI":"10.1371\/journal.pone.0009599","article-title":"60kD Ro and nRNP A frequently initiate human lupus autoimmunity","volume":"5","author":"Heinlen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.06.015_bb0190","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2014.06.015_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-106-4-518","article-title":"Maternal and fetal outcome in neonatal lupus erythematosus","volume":"106","author":"McCune","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0200","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sj\u00f6gren syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2014.06.015_bb0205","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cca.2014.06.015_bb0210","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2014.06.015_bb0215","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2014.06.015_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s005350170111","article-title":"The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples","volume":"36","author":"Kisand","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cca.2014.06.015_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cca.2014.06.015_bb0230","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2004.060228","article-title":"Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease","volume":"54","author":"Israeli","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cca.2014.06.015_bb0235","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2012-302717","article-title":"Serological markers predict inflammatory bowel disease years before the diagnosis","volume":"62","author":"van Schaik","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cca.2014.06.015_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event","volume":"349","author":"Berger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0250","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJMc062467","article-title":"Antimyelin antibodies with no progression to multiple sclerosis","volume":"356","author":"Pelayo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0255","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/1352458510376406","article-title":"Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis","volume":"16","author":"Chan","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.cca.2014.06.015_bb0260","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1191\/1352458505ms1187sr","article-title":"Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis","volume":"11","author":"Lim","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.cca.2014.06.015_bb0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458506072189","article-title":"Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations","volume":"13","author":"Pittock","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.cca.2014.06.015_bb0270","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMc070489","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Berger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2014.06.015_bb0275","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458507077622","article-title":"Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS","volume":"13","author":"Tomassini","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.cca.2014.06.015_bb0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00415-006-0299-4","article-title":"Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF","volume":"254","author":"Kuhle","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.cca.2014.06.015_bb0285","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp.2005.077784","article-title":"Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event","volume":"77","author":"Rauer","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cca.2014.06.015_bb0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2007.00872.x","article-title":"Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort","volume":"116","author":"Greeve","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.cca.2014.06.015_bb0295","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1258\/acb.2011.011073","article-title":"Analytical error and interference in immunoassay: minimizing risk","volume":"48","author":"Sturgeon","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cca.2014.06.015_bb0300","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.autrev.2011.11.011","article-title":"Autoantibodies in patients with chronic hepatitis C virus infection: pitfalls for the diagnosis of rheumatic diseases","volume":"11","author":"Palazzi","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2014.06.015_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0009-8981(03)00133-5","article-title":"Reference intervals: an update","volume":"334","author":"Horn","year":"2003","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.06.015_bb0310","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/rheumatology\/kem006","article-title":"Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients","volume":"46","author":"Feitsma","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2014.06.015_bb0315","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12026-013-8396-9","article-title":"Genetics and autoantibodies","volume":"56","author":"Perricone","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.cca.2014.06.015_bb0320","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2014.06.015_bb0325","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/art.22380","article-title":"A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions","volume":"56","author":"van der Helm-van Mil","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2014.06.015_bb0330","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMp038142","article-title":"Autoantibodies in systemic lupus erythematosus\u2014there before you know it","volume":"349","author":"Shmerling","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:56:11Z","timestamp":1538528171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":66,"alternative-id":["S0009898114002733"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.015","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in pre-clinical autoimmune disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}